US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

100.96

-2.9700-2.86%

Volume:6K

Turnover:609.62K

Market Cap:121.15M

PE:- -

High:104.53

Open:104.53

Low:100.91

Close:103.93

52wk High:110.05

52wk Low:68.05

Shares:1.20M

Float Shares:1.20M

Volume Ratio:2.25

T/O Rate:0.50%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSL Seeks ASX Quotation for New Shares from Employee Incentive Plan

Sandoz invests USD 300 million in new Slovenian biosimilar facility to boost capacity

Ceryvyn Therapeutics Plans Issue of 3 Million Long-Dated Options

Qurient Plans Investor Roadshow at 2026 KIS BioTech Day in Singapore and Hong Kong

AI Integration Becomes Essential for Biopharma's Future, Says Henlius CEO

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

AcroMeta Moves Into Cell Therapy Logistics With Southeast Asia ATCLS Deal

Alphamab Oncology Reduces Float with Fresh Share Buyback Valued at HK$492,430

Trump: August jobs beat estimates, demands rate cut

Trump's Truth Social latest posts

Australian Housing Affordability at Record Low Even as Prices Slide

Bank of England’s Pill warns against ‘wait and see’ interest rates approach

The bond market rout is global. Here’s what’s driving it

SD Biotechnologies Faces KOSDAQ Delisting Decision After Improvement Period

Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference

Citizens biotechnology analyst holds analyst/industry conference call

Ajinomoto Advances Major Share Buyback, Plans Cancellation of Repurchased Stock

Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions

Latigo Biotherapeutics initiated with a Buy at Goldman Sachs

Actinogen Plans Major Share Placement to Bolster Funding Capacity

Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BBP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":100.9601,"timestamp":1789485906094,"preClose":103.9301,"halted":0,"volume":6016,"delay":0,"changeRate":-0.028576899281343892,"floatShares":1200004,"shares":1200004,"eps":0,"marketStatus":"Trading","change":-2.97,"latestTime":"09-15 11:25:49 EDT","open":104.53,"high":104.53,"low":100.905,"amount":609616.13952,"amplitude":0.034879,"askPrice":102.11,"askSize":100,"bidPrice":100.02,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.9301,"sharesOutstanding":600004,"nav":103.362,"aum":124035301.07,"bidAskSpread":0.00263,"preHourTrading":{"tag":"盘前","latestPrice":103.9301,"preClose":103.9301,"latestTime":"07:02 EDT","volume":1,"amount":103.9301,"timestamp":1789470128746,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":103.9499,"preClose":103.9301,"latestTime":"19:30 EDT","volume":11,"amount":1143.2311,"timestamp":1789428605785,"change":0.0198,"changeRate":0.000191,"amplitude":0},"volumeRatio":2.247506,"impliedVol":0.232,"impliedVolPercentile":0.5179},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1200004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.247506,"shares":1200004,"dividePrice":0,"high":104.53,"amplitude":0.034879,"preClose":103.9301,"low":100.905,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":100.9601,"eps":0,"divideRate":0,"volume":6016,"delay":0,"ttmEps":0,"open":104.53,"prevYearClose":79.9149,"prevWeekClose":103.4597,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":106.7132,"twentyDayClose":102.7277,"sixtyDayClose":90.012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665340152","title":"CSL Seeks ASX Quotation for New Shares from Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665340152","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665340152?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:53","pubTimestamp":1788850386,"startTime":"0","endTime":"0","summary":"CSL ( ($AU:CSL) ) has provided an announcement. CSL Limited is a global biotechnology company that develops and supplies vaccines, plasma-derived t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/csl-seeks-asx-quotation-for-new-shares-from-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/csl-seeks-asx-quotation-for-new-shares-from-employee-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","SYNB","DARP","BBP","IEIH","XT","BK4585","IBB","JDOC","BK4588","PBPH","LNGR","FWD","AGNG","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665342499","title":"Sandoz invests USD 300 million in new Slovenian biosimilar facility to boost capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2665342499","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665342499?lang=en_us&edition=fundamental","pubTime":"2026-09-08 13:33","pubTimestamp":1788845596,"startTime":"0","endTime":"0","summary":"Sandoz Group Ltd ( ($CH:SDZ) ) has provided an announcement. Sandoz plans to invest around USD 300 million in a new biosimilar drug substance facil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sandoz-invests-usd-300-million-in-new-slovenian-biosimilar-facility-to-boost-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sandoz-invests-usd-300-million-in-new-slovenian-biosimilar-facility-to-boost-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","CROC","USD","EUFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665344433","title":"Ceryvyn Therapeutics Plans Issue of 3 Million Long-Dated Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2665344433","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665344433?lang=en_us&edition=fundamental","pubTime":"2026-09-08 12:37","pubTimestamp":1788842272,"startTime":"0","endTime":"0","summary":"Opthea ( ($AU:CYV) ) just unveiled an update. Ceryvyn Therapeutics Limited, an ASX-listed biotechnology company trading under the code CYV, develop...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ceryvyn-therapeutics-plans-issue-of-3-million-long-dated-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ceryvyn-therapeutics-plans-issue-of-3-million-long-dated-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","SYNB","BK4539","FHLC","BBP","FWD","RSPH","BK4139","LNGR","XT","BK4585","BK4007","AGNG","IBB","IEIH","DARP","JDOC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665396581","title":"Qurient Plans Investor Roadshow at 2026 KIS BioTech Day in Singapore and Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665396581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665396581?lang=en_us&edition=fundamental","pubTime":"2026-09-07 11:12","pubTimestamp":1788750740,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Qurient Co., Ltd. ( ($KR:115180) ). Qurient Co., Ltd., a Korea-based biotechnology company, is seeking to raise...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qurient-plans-investor-roadshow-at-2026-kis-biotech-day-in-singapore-and-hong-kong?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qurient-plans-investor-roadshow-at-2026-kis-biotech-day-in-singapore-and-hong-kong?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IEIH","BBP","BK4588","JDOC","FHLC","IBB","LNGR","RSPH","AGNG","STmain","DARP","SYNB","XT","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158783895","title":"AI Integration Becomes Essential for Biopharma's Future, Says Henlius CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1158783895","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158783895?lang=en_us&edition=fundamental","pubTime":"2026-09-05 14:20","pubTimestamp":1788589217,"startTime":"0","endTime":"0","summary":"At the 2026 Yabuli Forum Summer Annual Meeting, held from September 4-6 in Chengdu, Sichuan, Zhu Jun, CEO of HENLIUS, stated that the primary mission of the healthcare industry is to help people live...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","HK0000306701.USD","CHAT","IBBQ","HK0000165453.HKD","01477","QTOC","BK1191","BBP","02696","MRNX","AIPO","AGIX","HK0000320264.USD","ARTY","VTHR","MRNY","BK1161","BK1574","HK0000320223.HKD","03069"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","PTH","GNMX","MEDI","FFOX","EKG","BK4535","GNOM","XLVX","BBP","IDNA","GDOC","TECB","NVIB","PINK","HELX","MRNX","LU0889565916.HKD","TBXU","LU0320765992.SGD","BK4196","LABU","GH","LU0109394709.USD","BK4551","FRTY","IEIH","IBB","SYNB","IYH","BK4588","RSPH","BMED","MRNY","LFSC","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665355353","title":"AcroMeta Moves Into Cell Therapy Logistics With Southeast Asia ATCLS Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665355353","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665355353?lang=en_us&edition=fundamental","pubTime":"2026-09-05 00:46","pubTimestamp":1788540418,"startTime":"0","endTime":"0","summary":"AcroMeta Group Limited ( ($SG:43F) ) just unveiled an announcement. AcroMeta Group Limited has signed a non-binding term sheet with biotechnology f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acrometa-moves-into-cell-therapy-logistics-with-southeast-asia-atcls-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acrometa-moves-into-cell-therapy-logistics-with-southeast-asia-atcls-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4585","FWD","BK4588","IEIH","RSPH","AGNG","FHLC","DARP","JDOC","SG","XT","IBB","BK4209","LNGR","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179349089","title":"Alphamab Oncology Reduces Float with Fresh Share Buyback Valued at HK$492,430","url":"https://stock-news.laohu8.com/highlight/detail?id=1179349089","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179349089?lang=en_us&edition=fundamental","pubTime":"2026-09-04 22:20","pubTimestamp":1788531633,"startTime":"0","endTime":"0","summary":"Alphamab Oncology (stock code: 09966) has executed a share buyback on the Hong Kong Stock Exchange, purchasing a total of 56,000 ordinary shares during the trading session on September 4, 2026....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","IBBQ","CNAV","EWH","MRNY","03069","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665736309","title":"Trump: August jobs beat estimates, demands rate cut","url":"https://stock-news.laohu8.com/highlight/detail?id=2665736309","media":"Trump's Truth Social latest posts","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665736309?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:41","pubTimestamp":1788529306,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"724a78f70d7146f1ab07ec048eae1639","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trumpstruth.org/statuses/41509","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLIX","PEVC","DFUV","FXL","TSLP","IJK","LRCY","RJZ","CAOS",".SPX",".DJI","KOMP","BBP","ANEW","AVSD","UCC","VAW","FXR",".IXIC","CGDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664884573","title":"Australian Housing Affordability at Record Low Even as Prices Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2664884573","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664884573?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:25","pubTimestamp":1788485100,"startTime":"0","endTime":"0","summary":"SYDNEY--Despite sharp falls in house prices across Australia over recent months, housing affordability still slumped to its lowest level on record in the second quarter.The Housing Industry Associatio","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FXR","TSLQ","FXL","AVSD","ELOL","KOMP","TSLL","DFUV","PEVC","IJK","09766","TSYY","09366","RJZ","TLA","TSLG","TESC","VAW","CAOS","TSLO","BK4588","ANEW","TSII","CRSH","07366","TSLS","CLIX","TSLY","LRCY","CGDV","BBP","TESL","TEST","TSLW","TSLT","TSLR","TSLZ","TSDD","TSL","TSLI","BK4585","07766","TSLP","UCC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664680309","title":"Bank of England’s Pill warns against ‘wait and see’ interest rates approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2664680309","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664680309?lang=en_us&edition=fundamental","pubTime":"2026-09-03 23:32","pubTimestamp":1788449558,"startTime":"0","endTime":"0","summary":"Huw Pill widely viewed to be the Bank of England's most hawkish rate-setter The Bank of England’s chief economist has warned that a “wait and see approach” to setting interest rates amid the ongoing Iran war could unleash a fresh wave of inflation that the central bank will find hard to contain if left unchecked.Huw Pill, who has long been one of the most hawkish rate-setters on the Monetary Policy Committee, warned that while so-called second-round effects from the conflict are unlikely to be as severe as at the start of Russia’s invasion of Ukraine, officials may still find themselves playing catch-up without proactive action.“The problem with… a wait-and-see approach is that these uncertainties may not resolve themselves as quickly or definitively as we would hope, leading to a status quo bias in the setting of Bank Rate,” he told a group of business leaders in Scotland. “In turn, such a bias could lead monetary policy to fall ‘behind-the-curve’ in addressing emerging inflationary r","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/09/bank-of-england-chief-economist-huw-pill.jpg?w=286&h=161&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/09/bank-of-england-chief-economist-huw-pill.jpg?w=286&h=161&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bank-of-englands-pill-warns-against-wait-and-see-interest-rates-approach/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bank-of-englands-pill-warns-against-wait-and-see-interest-rates-approach/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["FXR","TLA","TSLT","CRSH","09766","BK4582","TSLO","BBP","VAW","KOMP","TACN","TSLG","IDEV","TSYY","IJK","09366","07766","BK4585","ANEW","TSLS","CGDV","TSLP","TSLZ","TSLR","CLIX","TSLY","UCC","TSLL","PEVC","RJZ","TSL","BK4588","LRCY","FXL","DFUV","ISVL","CAOS","TSLI","TSLQ","TSDD","TESC","07366","TESL","TSLW","FLGB","ELOL","TEST","AVSD","BBEU","TSII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664280830","title":"The bond market rout is global. Here’s what’s driving it","url":"https://stock-news.laohu8.com/highlight/detail?id=2664280830","media":"CNN Business","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664280830?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:21","pubTimestamp":1788445292,"startTime":"0","endTime":"0","summary":"The rise in bond yields is a global phenomenon, rooted in investors’ unease over unchecked government spending and intensified by bets that central banks may keep interest rates higher for longer.The US Treasury market gets the attention as the largest and most influential bond market in the world. But yields are also rising on government bonds in France, Germany, Italy, the United Kingdom, Japan, Canada and Australia.Yields this week touched multi-year and multi-decade highs. Investors are selling bonds, pushing prices lower and yields higher. Yields rise when bond prices fall.Bond yields set interest rates across the economy, and a steep rise in yields can raise the cost of mortgages, auto loans and student borrowing, making life less affordable.“At this stage, the bond market is not signaling a crisis,” Kristian Kerr, head of macro strategy at LPL Financial, wrote in a note. “However, it is sending a warning that merits attention.”Bond yields were lower Thursday. The bond market is ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"cnn_highlight","url":"https://edition.cnn.com/2026/09/03/investing/bond-market-global-economy","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://edition.cnn.com/2026/09/03/investing/bond-market-global-economy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cnn_highlight","symbols":["FXL","DIVZ","TSLW","07366","TSL","09766","BK4588","TESC","TEST","TSLO","TSDD","IJK","BK4585","CGDV","TSYY","TSLZ","ELOL","BNDW","CRSH","TSLI","CLIX","TSLL","VAW","JPIE","EQRR","TSLP","TESL","ANEW","TSLQ","LRCY","TSLG","FXR","AVSD","TSLR","07766","PEVC","DFUV","TLA","TSII","09366","BBP","TSLT","UCC","KOMP","RJZ","TSLS","UITB","CAOS","TSLY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664928878","title":"SD Biotechnologies Faces KOSDAQ Delisting Decision After Improvement Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2664928878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664928878?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:15","pubTimestamp":1788426920,"startTime":"0","endTime":"0","summary":"SD Biotechnologies Co., Ltd. ( ($KR:217480) ) has issued an update. SD Biotechnologies Co., Ltd., a KOSDAQ-listed biotechnology company, is under r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sd-biotechnologies-faces-kosdaq-delisting-decision-after-improvement-period?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sd-biotechnologies-faces-kosdaq-delisting-decision-after-improvement-period?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","RSPH","AGNG","BBP","BK4588","IBB","SYNB","XT","IEIH","JDOC","FWD","DARP","BK4585","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664214842","title":"Alterity Therapeutics to Spotlight MSA Program at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664214842","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664214842?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:47","pubTimestamp":1788392845,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) has provided an update. Alterity Therapeutics, a clinical-stage biotechnology company developing disease-modify...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-cantor-global-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","LU0128526141.USD","BK4588","BK4137","BK4581","IBB","FHLC","SYNB","LNGR","FWD","IEIH","LENZ","AGNG","RSPH","BK4007","XBI","BBC","BBP","LABU","XT","BK4139","LU0029874061.USD","HCSG","DARP","BK4539","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664843934","title":"Citizens biotechnology analyst holds analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2664843934","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664843934?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:45","pubTimestamp":1788367511,"startTime":"0","endTime":"0","summary":"Analysts discuss showcasing Twilio’s (TWLO) SIGNAL highlights on an Analyst/Industry conference call to be held on September 4. Published first on ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citizens-biotechnology-analyst-holds-analyst-industry-conference-call-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citizens-biotechnology-analyst-holds-analyst-industry-conference-call-thefly-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4116","LU1861558580.USD","BK4613","LU0106261612.USD","IAT","TWLO","SYNB","JDOC","LU0345770308.USD","LU1548497426.USD","CLOU","LU0205193047.USD","LU0345770993.USD","LU0205194284.USD","LU0106831901.USD","LU2357305700.SGD","LU1861559042.SGD","BK4551","DARP","LU1668664300.SGD","BK4588","LU0012050646.USD","LU1791807156.HKD","LU2237438978.USD","XT","LU0738911758.USD","BK4585","AGNG","LNGR","FHLC","IBB","LU1720051108.HKD","BK4528","CFG","BK4211","BK4548","LU0661504455.SGD","RSPH","LU1720051017.SGD","LU0949170772.SGD","BBP","BK4608","IEIH","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891664","title":"Ajinomoto Advances Major Share Buyback, Plans Cancellation of Repurchased Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891664","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891664?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:53","pubTimestamp":1788331999,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Ajinomoto Co ( ($JP:2802) ). Ajinomoto Co., Inc., a leading Japanese food and biotechnology group listed on the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ajinomoto-advances-major-share-buyback-plans-cancellation-of-repurchased-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ajinomoto-advances-major-share-buyback-plans-cancellation-of-repurchased-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","FHLC","BK4588","DARP","BBP","JDOC","LNGR","RSPH","SYNB","XT","BK4585","IEIH","IBB","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664997828","title":"Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2664997828","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664997828?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:21","pubTimestamp":1788330080,"startTime":"0","endTime":"0","summary":"Aptabio Therapeutics, Inc. ( ($KR:293780) ) has provided an update. Aptabio Therapeutics, Inc., a biotechnology company focused on research and dev...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aptabio-therapeutics-plans-seoul-ndr-to-deepen-rd-dialogue-with-institutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aptabio-therapeutics-plans-seoul-ndr-to-deepen-rd-dialogue-with-institutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4007","IBB","IEIH","BK4585","BK4539","DARP","FWD","BBP","JDOC","LENZ","AGNG","LNGR","SYNB","FHLC","RSPH","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664883471","title":"Latigo Biotherapeutics initiated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2664883471","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664883471?lang=en_us&edition=fundamental","pubTime":"2026-09-01 16:30","pubTimestamp":1788251407,"startTime":"0","endTime":"0","summary":"Goldman Sachs initiated coverage of Latigo Biotherapeutics (LTGO) with a Buy rating and $73 price target Latigo is clinical-stage biotechnology com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/latigo-biotherapeutics-initiated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","LU0942090050.USD","LU2471134796.USD","LU2237443549.SGD","LU0251131958.USD","LU0106831901.USD","LU1868836914.USD","BK4504","LU0345770993.USD","LU1868837136.USD","SYNB","GSX","BK4127","FWD","LU1894683348.USD","IE0004086264.USD","LU1668664300.SGD","IE00B19Z3B42.SGD","BK4516","LU2896262040.SGD","LU2237438978.USD","LTGO","LU2237443895.HKD","LU2471134523.USD","LU2237443382.USD","IBB","BK4552","RSPH","BK4550","BBP","JDOC","IE0004091025.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU1868836757.USD","LU2237443622.USD","AGNG","IE00BFXG1179.USD","LU1144417596.USD","DARP","BK4007","BBC","LNGR","BK4585","XT","LU0868494617.USD","LU0210536198.USD","LU1868836591.USD","LU0096364046.USD","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881767","title":"Actinogen Plans Major Share Placement to Bolster Funding Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881767","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:46","pubTimestamp":1788223606,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) just unveiled an update. Actinogen Medical Limited, an ASX-listed biotechnology company trading under the code ACW,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","FWD","IEIH","SYNB","RSPH","JDOC","BK4588","BK4585","LNGR","IBB","BBP","DARP","AGNG","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663753250","title":"Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2663753250","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663753250?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165205,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has shared an announcement. Chimeric Therapeutics Limited is a biotechnology company focused on cell-based...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","IBB","LNGR","BK4588","AGNG","XT","BK4007","LENZ","BBP","SYNB","IEIH","BK4139","BK4539","FWD","FHLC","BK4585","JDOC","DARP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":2,"totalSize":162,"code":"91000000","status":"200"}]}}